J. Alexieva-Figusch

Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.

John A. Foekens, Henk Portengen, W L van Putten et al. · PubMed · 1989 · 219 citations

Epidermal Growth Factor, Breast Oncology, Growth Hormone +14

Antiprogestins, a new form of endocrine therapy for human breast cancer.

J.G.M. Klijn, FH de Jong, G.H. Bakker et al. · PubMed · 1989 · 142 citations

Breast Oncology, Gynecology, Human Breast Cancer +18

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study

Jan G.M. Klijn, Maxime P. Look, Henk Portengen et al. · Breast Cancer Research and Treatment · 1994 · 122 citations

Breast Oncology, Medicine, Prognostic Value +9

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.

John A. Foekens, Henk Portengen, W L van Putten et al. · PubMed · 1989 · 117 citations

Breast Oncology, Gynecology, Mammary Gland Development +16

Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.

F.A.G. Teulings, H.A. van Gilse, M.S. Henkelman et al. · PubMed · 1980 · 103 citations

Breast Oncology, Progesterone Receptors, Progestin-induced Regression +13